Mast Therapeutics, Inc. (NYSEMKT:MSTX) will report its next earnings on Nov 10 – Nov 14 (Est.). The company reported the earnings of $-0.05/Share in the last quarter where the estimated EPS by analysts was $-0.06/share. The difference between the expected and actual EPS was $0.01/share, which represents an Earnings surprise of 16.7%.
Many analysts are providing their Estimated Earnings analysis for Mast Therapeutics, Inc. and for the current quarter 5 analysts have projected that the stock could give an Average Earnings estimate of $-0.05/share. These analysts have also projected a Low Estimate of $-0.05/share and a High Estimate of $-0.04/share.
Some buy side analysts are also providing their Analysis on Mast Therapeutics, Inc., where 1 analysts have rated the stock as Strong buy, 5 analysts have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. 3 Analysts reported that the Price Target for Mast Therapeutics, Inc. might touch $5 high while the Average Price Target and Low price Target is $3.5 and $2.5 respectively.
To analyze a stock, one should look for Upgrades and Downgrades of a stock. Mast Therapeutics, Inc. got Downgrade on 21-Sep-16 where investment firm Maxim Group Downgrade the stock from Buy to Hold.
Mast Therapeutics, Inc. closed its last trading session at $0.09 with the loss of -0.24%. The Market Capitalization of the company stands at 19.4 Million. The Company has 52-week high of $0.71 and 52-week low of $0.08. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -34.14% where SMA50 and SMA200 are -74.59% and -75.65% respectively. The Company Touched its 52-Week High on Sep 6, 2016 and 52-Week Low on Oct 17, 2016.
The Relative Volume of the company is 0.81 and Average Volume (3 months) is 8.8 million. Mast Therapeutics, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.
The company shows its Return on Assets (ROA) value of -77.9%. The Return on Equity (ROE) value stands at -177.7%. While it’s Return on Investment (ROI) value is 0%.
While looking at the Stock’s Performance, Mast Therapeutics, Inc. currently shows a Weekly Performance of -15.2%, where Monthly Performance is -85.63%, Quarterly performance is -80.28%, 6 Months performance is -74.3% and yearly performance percentage is -82.69%. Year to Date performance value (YTD perf) value is -79.81%. The Stock currently has a Weekly Volatility of 10.38% and Monthly Volatility of 12.89%.